Volume 72, Number 24, June 16, 2009
About this course
- Released: 06/15/2009
- Expires: 06/16/2011
Learning Objectives:
Upon completion of the article by Makhani et al., the participant should be able to:
• State how the frequency of relapses compares between adults and children with multiple sclerosis (MS)
• State how cyclophosphamide treatment altered the number of attacks per year of MS
• State how cyclophosphamide treatment affected the Expanded Disability Status Scale (EDSS) for children with MS
Core Competencies:
The article by Makhani et al. covers the following core competency:
• Medical Knowledge
Learning Objectives:
Upon completion of the article by Duh et al., the participant should be able to:
• State the rate of switching back from generic to brand name antiepileptic drugs (AEDs) versus non-epileptic drugs (non-AEDs)
• Discuss how the use of multiple generic forms of topiramate affected the use of other AEDs and non-AEDs
• Discuss how the incidence ratio rate for hospitalization and length of stay differed with multiple-generic usage
Core Competencies:
The article by Duh et al. covers the following core competency:
• Medical Knowledge
Author Disclosures: Refer to listing above the references in each article.
THIS PAGE IS REQUIRED READING BEFORE BEGINNING ALL ACCME-ACCREDITED COURSES
ACCREDITATION STATEMENT
The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed. Physicians should only claim credit commensurate with the extent of their participation in the activity. The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
MISSION STATEMENT/PROGRAM OBJECTIVES
After evaluating a specific article published in Neurology, participants in the CME activity should be able to demonstrate an increase in, or affirmation of, their knowledge of clinical medicine. Participants should be able to evaluate the appropriateness of the clinical information as it applies to the provision of patient care.
PARTICIPANTS
This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.
CREDITS
The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed.
The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.
DISCLOSURES
Steven Lewis, MD, has received personal compensation in an editorial capacity for the National Board of Medical Examiners and the American College of Physicians; Paul Schulz, MD, has received personal compensation for activities with Pfizer.
COMMERCIAL SUPPORT
This CME program receives no commercial support.
